337. ホモシスチン尿症 Homocystinuria Clinical trials / Disease details
臨床試験数 : 16 / 薬物数 : 19 - (DrugBank : 7) / 標的遺伝子数 : 2 - 標的パスウェイ数 : 23
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | EUCTR2006-000614-21-IT (EUCTR) | 11/12/2006 | 05/10/2007 | A multicentre, open-label study to evaluate the efficacy and safety of 5-MTHF administration, added on to the individual established therapy, on plasma homocysteine levels in patients with congenital homocystinuria - ND | A multicentre, open-label study to evaluate the efficacy and safety of 5-MTHF administration, added on to the individual established therapy, on plasma homocysteine levels in patients with congenital homocystinuria - ND | Homocystinuria MedDRA version: 6.1;Level: PT;Classification code 10020365 | Trade Name: PREFOLIC 15*30CPR GASTROR 15MG INN or Proposed INN: Detoxifying agents for antineoplastic treatment | ZAMBON GROUP | NULL | Not Recruiting | Female: yes Male: yes | 22 | Hungary;United Kingdom;Italy;Austria |